Detalles de la búsqueda
1.
Letermovir prophylaxis is effective in preventing cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation: single-center real-world data.
Ann Hematol
; 100(8): 2087-2093, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33270162
2.
Long-Term Survivors after Failure of Chimeric Antigen Receptor T Cell Therapy for Large B Cell Lymphoma: A Role for Allogeneic Hematopoietic Cell Transplantation? A German Lymphoma Alliance and German Registry for Stem Cell Transplantation Analysis.
Transplant Cell Ther
; 29(12): 750-756, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37709204
3.
Treatment of adult ALL patients with third-generation CD19-directed CAR T cells: results of a pivotal trial.
J Hematol Oncol
; 16(1): 79, 2023 07 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-37481608
4.
Infection Complications after Lymphodepletion and Dosing of Chimeric Antigen Receptor T (CAR-T) Cell Therapy in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia or B Cell Non-Hodgkin Lymphoma.
Cancers (Basel)
; 13(7)2021 Apr 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33918340
5.
Genome editing in clinical practice: A model study for next-gen hematopoietic cell transplants in hematologic malignancies.
Mol Ther Methods Clin Dev
; 32(1): 101210, 2024 Mar 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38435129
6.
HLA class I loss in metachronous metastases prevents continuous T cell recognition of mutated neoantigens in a human melanoma model.
Oncotarget
; 8(17): 28312-28327, 2017 Apr 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-28423700
Resultados
1 -
6
de 6
1
Próxima >
>>